DFFN - Diffusion Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
6,327
5,752
5,089
7,252
Selling General and Administrative
4,979
6,167
6,192
11,094
Total Operating Expenses
11,406
12,029
11,348
18,372
Operating Income or Loss
-11,406
-12,029
-11,348
-18,372
Interest Expense
-
152
48
30
Total Other Income/Expenses Net
-
-6,929
11,846
0
Income Before Tax
-14,058
-18,807
-2,420
-18,401
Income Tax Expense
-440
-437
-1,056
-365
Income from Continuing Operations
-13,618
-18,370
-1,365
-18,037
Net Income
-13,618
-18,370
-1,365
-18,037
Net Income available to common shareholders
-13,618
-26,624
-2,617
-18,037
Reported EPS
Basic
-
-8.21
-3.15
-26.40
Diluted
-
-8.21
-29.10
-26.44
Weighted average shares outstanding
Basic
-
3,242
830
682
Diluted
-
3,242
850
682
EBITDA
-
-18,545
-2,304
-18,346